✉news WorldLaw & Courts first seen 19 h ago, last 19 h ago, peak #30
Liquidia shares plunge after court ruling in United Therapeutics patent fight
Original: Liquidia plunges amid court ruling in United Therapeutics patent fight
Liquidia's stock fell sharply following a court ruling in its long-running patent dispute with United Therapeutics over its lead pulmonary hypertension drug. The litigation, centered on United Therapeutics' claims that Liquidia infringed patents tied to treprostinil therapies, has weighed on the company for years, and investors reacted quickly to the latest adverse development in court.
Why now: A court decision in the high-stakes patent case triggered a sharp drop in Liquidia's share price, prompting investor reaction.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/511596